![](/img/cover-not-exists.png)
Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs: A Multi Criteria Decision Analysis For Rituximab And Bevacizumab
van Steen, C, Cakar, E, Treur, M, Verbeek, NA, Franken, MVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.1722
Date:
October, 2017
File:
PDF, 59 KB
english, 2017